{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:54:51Z","timestamp":1769835291992,"version":"3.49.0"},"reference-count":48,"publisher":"EDITORA SCIENTIFIC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"DOI":"10.1590\/1516-4446-2016-2058","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T03:10:28Z","timestamp":1490325028000},"page":"228-236","source":"Crossref","is-referenced-by-count":23,"title":["Chronic dosing with mirtazapine does not produce sedation in rats"],"prefix":"10.47626","volume":"39","author":[{"given":"Alberto","family":"Salazar-Ju\u00e1rez","sequence":"first","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Barbosa-M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Merino-Reyes","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Matus-Ortega","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Hern\u00e1ndez-Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Ant\u00f3n","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz,  Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27448","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis","volume":"78","author":"Torrens M","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199512004-00004","article-title":"The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission","volume":"10","author":"de Boer T","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"ref3","first-page":"748","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol","volume":"73","author":"Chanrion B","year":"2008","journal-title":"Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama K","year":"2004","journal-title":"Brain Res Bull"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani A","year":"2009","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4088\/JCP.v69n0908","article-title":"Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis","volume":"69","author":"Watanabe N","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"ref7","first-page":"CD006528","article-title":"Mirtazapine versus other antidepressive agents for depression","volume":"12","author":"Watanabe N","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hup.561","article-title":"Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs","volume":"19","author":"Bourin M","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11319480-000000000-00000","article-title":"Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis","volume":"24","author":"Watanabe N","year":"2010","journal-title":"CNS Drugs"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hup.2327","article-title":"Effects of low-dose mirtazapine on driving performance in healthy volunteers","volume":"28","author":"Iwamoto K","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila SA","year":"2001","journal-title":"CNS Drug Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMra050730","article-title":"The medical management of depression","volume":"353","author":"Mann JJ","year":"2005","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0029-1231076","article-title":"Prescribing a sedative antidepressant for patients at work or on sick leave under conditions of routine care","volume":"43","author":"Linden M","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-199717040-00005","article-title":"A risk-benefit assessment of mirtazapine in the treatment of depression","volume":"17","author":"Kasper S","year":"1997","journal-title":"Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/YIC.0000000000000035","article-title":"Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia","volume":"29","author":"Poyurovsky M","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2005-864120","article-title":"Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice","volume":"38","author":"Grasm\u00e4der K","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S0924-977X(97)88520-3","article-title":"Tolerability of mirtazapine used in high or low initial dose","volume":"7","author":"Stahl SM","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref18","first-page":"82","article-title":"Mirtazapine safety and tolerability: analysis of the clinical trials database","volume":"96","author":"Stimmel GL","year":"1997","journal-title":"Prim Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hup.2321","article-title":"Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers","volume":"28","author":"Sasada K","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1142\/S0192415X1550041X","article-title":"Artemisia capillaris Thunberg produces sedative-hypnotic effects in mice, which are probably mediated through potentiation of the GABA(A) receptor","volume":"43","author":"dela Pe\u00f1a IJ","year":"2015","journal-title":"Am J Chin Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1023\/A:1012067703764","article-title":"Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations","volume":"14","author":"Timmer CJ","year":"1997","journal-title":"Pharm Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2016.02.010","article-title":"Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats","volume":"68","author":"Salazar-Ju\u00e1rez A","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref23","first-page":"397","article-title":"Comparative study of neuroprotective effect of tricyclics vs. trazodone on animal model of depressive disorder","volume":"53","author":"Marinescu IP","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"ref24","first-page":"e2609","article-title":"Measuring motor coordination in mice","volume":"75","author":"Deacon RM","year":"2013","journal-title":"J Vis Exp"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom KF","year":"2009","journal-title":"CNS Drugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti A","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/0269881107083808","article-title":"A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder","volume":"22","author":"Papakostas GI","year":"2008","journal-title":"J Psychopharmacol"},{"key":"ref28","first-page":"389","article-title":"Mirtazipine: a review of its pharmacology and therapeutic potential in the management of major depression","volume":"5","author":"Davis R","year":"1996","journal-title":"CNS Drugs"},{"key":"ref29","first-page":"215","article-title":"The effects of mirtazapine on sleep in patients with major depressive disorder","volume":"24","author":"Dolder CR","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.sleep.2004.06.004","article-title":"Effectiveness of mirtazapine in the treatment of sleep apnea\/hypopnea syndrome (SAHS)","volume":"5","author":"Castillo JL","year":"2004","journal-title":"Sleep Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/sleep\/30.1.35","article-title":"Efficacy of mirtazapine in obstructive sleep apnea syndrome","volume":"30","author":"Carley DW","year":"2007","journal-title":"Sleep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/appy.12060","article-title":"Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder","volume":"6","author":"Wang D","year":"2014","journal-title":"Asia Pac Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","article-title":"Rediscovering trazodone for the treatment of major depressive disorder","volume":"26","author":"Fagiolini A","year":"2012","journal-title":"CNS Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl SM","year":"2009","journal-title":"CNS Spectr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1098612X15587956","article-title":"Use of oral trazodone for sedation in cats: a pilot study","volume":"18","author":"Orlando JM","year":"2016","journal-title":"J Feline Med Surg"},{"key":"ref36","first-page":"23","article-title":"Trazodone dosing regimen: experience with single daily administration","volume":"51","author":"Fabre LF","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1176\/ajp.151.7.1069","article-title":"Trazodone for antidepressant-associated insomnia","volume":"151","author":"Nierenberg AA","year":"1994","journal-title":"Am J Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0253-7613.93843","article-title":"Efficacy and safety of add on low-dose mirtazapine in depression","volume":"44","author":"Matreja PS","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00004714-200010000-00006","article-title":"Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens","volume":"20","author":"Radhakishun FS","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2010.09.032","article-title":"Mirtazapine alters cue-associated methamphetamine seeking in rats","volume":"69","author":"Graves SM","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/BF00172626","article-title":"A comparison of two oral dosage regimens of 150 mg trazodone in the treatment of depression in general practice","volume":"95","author":"Davey A","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/srep19796","article-title":"Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice","volume":"6","author":"Bittolo T","year":"2016","journal-title":"Sci Rep"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment","volume":"86","author":"Muguruza C","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004714-200210000-00012","article-title":"Tolerance to daytime sedative effects of H1 antihistamines","volume":"22","author":"Richardson GS","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v64n0106","article-title":"Antidepressants and driver impairment: empirical evidence from a standard on-the-road test","volume":"64","author":"Ramaekers JG","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0165-0327(14)70007-2","article-title":"Managing the side effects associated with commonly used treatments for bipolar depression","volume":"169","author":"Kemp DE","year":"2014","journal-title":"J Affect Disord"},{"key":"ref47","first-page":"18","article-title":"Atypical antipsychotics: sedation versus efficacy","volume":"69","author":"Kane JM","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"ref48","first-page":"337","article-title":"[Mirtazapine in the treatment of cocaine-dependence in patients with methadone]","volume":"30","author":"Zueco-P\u00e9rez PL","year":"2002","journal-title":"Actas Esp Psiquiatr"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v39n3\/1516-4446-rbp-1516444620162058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:10:54Z","timestamp":1654531854000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462017000300007&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["S1516-44462017000300007"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2016-2058","relation":{},"ISSN":["1809-452X","1516-4446"],"issn-type":[{"value":"1809-452X","type":"electronic"},{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}